Ignite Creation Date:
2024-05-06 @ 8:38 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02789332
Status:
COMPLETED
Last Update Posted:
2020-03-17
First Post:
2016-05-23
Brief Title:
Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel Carboplatin Followed by EpirubicinCyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency
Sponsor:
German Breast Group
Organization:
German Breast Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| BRCA 1 2 and or HRD |
| Breast Cancer |
| Triple Negative Breast Neoplasms |
| HRpos Breast Neoplasms |